A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries

被引:78
作者
Rader, C
Cheresh, DA
Barbas, CF
机构
[1] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.95.15.8910
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
development of a new strategy for antibody humanization is described. This strategy incorporates key recognition sequences from the parental rodent antibody into a phage display-based selection strategy. The original sequences of the third complementarity-determining regions (CDRs) of heavy and light chains, HCDR3 and LCDR3, were maintained and all other sequences were replaced by human sequences selected from phage-displayed antibody libraries. This approach was applied to the humanization of mouse mAb LM609 that is directed to human integrin alpha(v)beta(3) and has potential applicability in cancer therapy as an antiangiogenic agent. We demonstrate this approach (i) provides a rapid route for antibody humanization constraining the content of original mouse sequences in the final antibodies to the most hypervariable of the CDRs; (ii) generates several humanized versions with different sequences at the same time; (iii) results in affinities as high as or higher than the affinity of the original antibody; and (iv) retains the antigen and epitope specificity of the original antibody. The production of multiple humanized variants may present advantages in the selection of antibodies that are more readily expressed on a large scale and could be important in therapeutic regimens that call for long-term treatment with antibodies in which antiidiotypic responses might be avoided by administration of alternative antibodies.
引用
收藏
页码:8910 / 8915
页数:6
相关论文
共 41 条
  • [1] Baca M, 1997, J BIOL CHEM, V272, P10678
  • [2] SYNTHETIC HUMAN-ANTIBODIES
    BARBAS, CF
    [J]. NATURE MEDICINE, 1995, 1 (08) : 837 - 839
  • [3] ASSEMBLY OF COMBINATORIAL ANTIBODY LIBRARIES ON PHAGE SURFACES - THE GENE-III SITE
    BARBAS, CF
    KANG, AS
    LERNER, RA
    BENKOVIC, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) : 7978 - 7982
  • [4] HIGH-AFFINITY SELF-REACTIVE HUMAN-ANTIBODIES BY DESIGN AND SELECTION - TARGETING THE INTEGRIN LIGAND-BINDING SITE
    BARBAS, CF
    LANGUINO, LR
    SMITH, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) : 10003 - 10007
  • [5] MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES
    BARBAS, CF
    COLLET, TA
    AMBERG, W
    ROBEN, P
    BINLEY, JM
    HOEKSTRA, D
    CABABA, D
    JONES, TM
    WILLIAMSON, RA
    PILKINGTON, GR
    HAIGWOOD, NL
    CABEZAS, E
    SATTERTHWAIT, AC
    SANZ, I
    BURTON, DR
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) : 812 - 823
  • [6] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [7] ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN
    BROOKS, PC
    STROMBLAD, S
    KLEMKE, R
    VISSCHER, D
    SARKAR, FH
    CHERESH, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 1815 - 1822
  • [8] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
    BROOKS, PC
    MONTGOMERY, AMP
    ROSENFELD, M
    REISFELD, RA
    HU, TH
    KLIER, G
    CHERESH, DA
    [J]. CELL, 1994, 79 (07) : 1157 - 1164
  • [9] HIGH-LEVEL ESCHERICHIA-COLI EXPRESSION AND PRODUCTION OF A BIVALENT HUMANIZED ANTIBODY FRAGMENT
    CARTER, P
    KELLEY, RF
    RODRIGUES, ML
    SNEDECOR, B
    COVARRUBIAS, M
    VELLIGAN, MD
    WONG, WLT
    ROWLAND, AM
    KOTTS, CE
    CARVER, ME
    YANG, M
    BOURELL, JH
    SHEPARD, HM
    HENNER, D
    [J]. BIO-TECHNOLOGY, 1992, 10 (02): : 163 - 167